KR100256473B1 - 1-카바-(데티아)-세팔로스포린유도체 - Google Patents

1-카바-(데티아)-세팔로스포린유도체 Download PDF

Info

Publication number
KR100256473B1
KR100256473B1 KR1019970048181A KR19970048181A KR100256473B1 KR 100256473 B1 KR100256473 B1 KR 100256473B1 KR 1019970048181 A KR1019970048181 A KR 1019970048181A KR 19970048181 A KR19970048181 A KR 19970048181A KR 100256473 B1 KR100256473 B1 KR 100256473B1
Authority
KR
South Korea
Prior art keywords
oxo
amino
lower alkyl
oct
aza
Prior art date
Application number
KR1019970048181A
Other languages
English (en)
Korean (ko)
Other versions
KR19980024863A (ko
Inventor
파울 헤바이젠
잉그리트 하인제-크라우스
페터 앙게흐른
말콤 페이지
Original Assignee
프리돌린 클라우스너, 롤란드 비. 보레르
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리돌린 클라우스너, 롤란드 비. 보레르, 에프. 호프만-라 로슈 아게 filed Critical 프리돌린 클라우스너, 롤란드 비. 보레르
Publication of KR19980024863A publication Critical patent/KR19980024863A/ko
Application granted granted Critical
Publication of KR100256473B1 publication Critical patent/KR100256473B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1019970048181A 1996-09-23 1997-09-23 1-카바-(데티아)-세팔로스포린유도체 KR100256473B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96115210 1996-09-23
EP96115210.5 1996-09-23

Publications (2)

Publication Number Publication Date
KR19980024863A KR19980024863A (ko) 1998-07-06
KR100256473B1 true KR100256473B1 (ko) 2000-05-15

Family

ID=8223209

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970048181A KR100256473B1 (ko) 1996-09-23 1997-09-23 1-카바-(데티아)-세팔로스포린유도체

Country Status (23)

Country Link
US (1) US5939410A (fr)
JP (1) JPH10101670A (fr)
KR (1) KR100256473B1 (fr)
CN (1) CN1184110A (fr)
AR (1) AR008450A1 (fr)
AU (1) AU723176B2 (fr)
BR (1) BR9704770A (fr)
CA (1) CA2216222A1 (fr)
CO (1) CO4900072A1 (fr)
CZ (1) CZ292097A3 (fr)
HR (1) HRP970511A2 (fr)
HU (1) HUP9701548A3 (fr)
ID (1) ID18323A (fr)
IL (1) IL121798A0 (fr)
MA (1) MA26442A1 (fr)
NO (1) NO974366L (fr)
NZ (1) NZ328595A (fr)
PE (1) PE110098A1 (fr)
PL (1) PL322240A1 (fr)
SG (1) SG53049A1 (fr)
TR (1) TR199701011A2 (fr)
YU (1) YU38497A (fr)
ZA (1) ZA978332B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100093532A (ko) * 2007-10-25 2010-08-25 아카오젠, 인코포레이티드 카바세펨 β―락탐 항생제
WO2010030810A1 (fr) * 2008-09-10 2010-03-18 Achaogen, Inc. Antibiotiques de type béta-lactame à base de carbacéphème

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112481A1 (fr) * 1982-11-12 1984-07-04 Kyowa Hakko Kogyo Co., Ltd Dérivé de bêta-lactame
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
PT620225E (pt) * 1993-04-16 2003-03-31 Basilea Pharmaceutica Ag Derivados de cefalosporina
CN1176641A (zh) * 1995-02-27 1998-03-18 弗·哈夫曼-拉罗切有限公司 3－吡咯烷亚基－2－酮－头孢菌素衍生物
EP0761673A1 (fr) * 1995-09-12 1997-03-12 F. Hoffmann-La Roche Ag Dérivés de céphalosporine

Also Published As

Publication number Publication date
ID18323A (id) 1998-03-26
CA2216222A1 (fr) 1998-03-23
US5939410A (en) 1999-08-17
CO4900072A1 (es) 2000-03-27
BR9704770A (pt) 1998-11-03
CN1184110A (zh) 1998-06-10
MA26442A1 (fr) 2004-12-20
NZ328595A (en) 1999-01-28
JPH10101670A (ja) 1998-04-21
HRP970511A2 (en) 1998-08-31
YU38497A (sh) 1999-12-27
PE110098A1 (es) 1999-01-13
IL121798A0 (en) 1998-02-22
AU723176B2 (en) 2000-08-17
SG53049A1 (en) 1998-09-28
MX9707201A (es) 1998-06-28
PL322240A1 (en) 1998-03-30
AR008450A1 (es) 2000-01-19
NO974366L (no) 1998-03-24
HU9701548D0 (en) 1997-11-28
KR19980024863A (ko) 1998-07-06
TR199701011A2 (xx) 1998-04-21
HUP9701548A2 (hu) 1999-05-28
HUP9701548A3 (en) 2001-04-28
CZ292097A3 (cs) 1998-04-15
ZA978332B (en) 1998-03-23
NO974366D0 (no) 1997-09-22
AU3838297A (en) 1998-01-15

Similar Documents

Publication Publication Date Title
EP0620225B1 (fr) Dérivés de céphalosporine
KR100395985B1 (ko) 염기성치환기를갖는비닐-피롤리디논세파로스포린
KR100309516B1 (ko) 세팔로스포린유도체
CZ251896A3 (en) Cephalosporin derivatives
KR100256473B1 (ko) 1-카바-(데티아)-세팔로스포린유도체
EP0831093A1 (fr) Dérivés de 1-carba-(déthia)-céphalosporine
PT86727B (pt) Processo para a preparacao de acidos carboxilicos beta-lactamicos biciclicos
US5811419A (en) Isooxacephem-derivatives
KR100414336B1 (ko) 프로페닐 세팔로스포린 유도체
KR100253783B1 (ko) 세팔로스포린 피리디늄 유도체
MXPA97007201A (es) Derivados de 1-carba-(detia)-cefalosporina
EP0838465A1 (fr) Dérivés de (lactamylvinyl)cephalosporin pyridinium substitués, leur préparation et leur utilisation comme antibiotiques
WO2000032605A1 (fr) Bi-pyrrolidinylvinyl (carba) cephalosporines
MXPA00012689A (en) Propenyl cephalosporin derivatives
CS216936B2 (cs) Způsob výroby derivátů 7/3-aminothiazolylacetainido- -3-cefem-4-karboxylové kyseliny

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee